| Cat.No. | Name | Information |
|---|---|---|
| M5316 | BLZ945 (Sotuletinib) | Sotuletinib (BLZ945) is an orally active, potent and selective CSF-1R inhibitor with IC50 of 1 nM, >1000-fold selective against its closest receptor tyrosine kinase homologs. |
| M2743 | GW2580 | GW2580 is a selective CSF-1R inhibitor for c-FMS with IC50 of 30 nM, 150- to 500-fold selective compared to b-Raf, CDK4, c-KIT, c-SRC, EGFR, ERBB2/4, ERK2, FLT-3, GSK3, ITK, JAK2 etc. |
| M43482 | Pimicotinib | Pimicotinib is a novel, orally bioavailable, highly selective small-molecule inhibitor of colony-stimulating factor 1 (CSF-1) with antitumor activity and less inhibitory effects on c-Kit and PDGFR. |
| M43479 | Sotuletinib hydrochloride | Sotuletinib (BLZ945) hydrochloride is a potent, selective and brain-penetrant CSF-1R (c-Fms) inhibitor with an IC50 of 1 nM. |
| M24957 | Axatilimab | Axatilimab (SNDX-6352) is a humanized IgG4 antibody with high affinity to CSF-1R. Axatilimab can be used for the research of chronic graft versus host disease (cGVHD) and neoplastic diseases. |
| M24547 | Mavrilimumab | Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF might be a mediator of the hyperactive inflammatory response associated with respiratory failure and death. |
| M11516 | Vimseltinib | Vimseltinib (DCC-3014) is a highly selective, orally active inhibitor of colony-stimulating factor-1 receptor (CSF-IR) and c-Kit with IC50 values of <0.01 μM and 0.1-1 μM, respectively.Vimseltinib is used in studies related to tenosynovial giant cell tumors (TGCT). |
| M10938 | AZD7507 | AZD7507 is a potent, oral CSF-1R inhibitor with antitumor activity. |
| M10937 | Edicotinib | Edicotinib (JNJ-40346527) is a potent, selective, blood-brain permeable and orally active CSF-1R inhibitor.IC50 3.2 nM. Edicotinib has less inhibitory effect on KIT and FLT3,IC50 The values are 20 nM and 190 nM, respectively. Edicotinib inhibits the expansion of microglia, weakens the proliferation of microglia and neurodegenerative degeneration. Edicotinib can be used in the study of Alzheimer's disease and rheumatoid arthritis. |
| M9685 | cFMS Receptor Inhibitor II | cFMS Receptor Inhibitor II is a CSF1R kinase inhibitor. |
| M9512 | PLX5622 | PLX5622 is a highly selective brain penetrant and oral active CSF1R inhibitor with an Ki of 5.9 nM. |
| M6865 | Ki 20227 | Ki 20227 is a c-Fms inhibitor; suppresses osteolysis and osteoclast accumulation. |
| M4955 | PLX647 | PLX647 is a highly specific dual FMS/KIT kinase inhibitor with IC50 of 28/16 nM respectively. |
| M57191 | ARRY-382 | ARRY-382 is a potent, oral and highly selective inhibitor of CSF1R/c-Fms with an IC50 of 9 nM. |
| M43943 | Tinengotinib | Tinengotinib is a modulator of several protein kinases, such as Aurora kinase, VEGFR kinase, and CSF-1R, etc. Tinengotinib can be used in studies related to diseases mediated by abnormalities in these kinases. |
| M43942 | AMG-820 | AMG-820 is an anti-colony stimulating factor 1 receptor (CSF1R) monoclonal antibody. |
| M43483 | CSF1R-IN-15 | CSF1R-IN-15 is an inhibitor targeting CSF1R. |
| M43481 | c-Fms-IN-14 | c-Fms-IN-14 is a c-Fms inhibitor with an IC50 value of 4 nM. |
| M43480 | CSF1R-IN-17 | CSF1R-IN-17 is a potent and selective CSF1R antagonist, with an IC50 of 0.2 nM. |
| M29163 | GENZ-882706 | GENZ-882706 is a potent colony stimulating factor-1 receptor (CSF-1R) inhibitor. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
